Every time the AI Express is announced,上海萊士（SZ 002252，收盤價：6.88元）3月26日晚間發佈公告稱，上海萊士血液製品股份有限公司擬以支付現金的方式收購南嶽生物製藥有限公司100%股權。本次交易基礎對價對應標的公司100%股權作價42億元，其中：約87.98%股權轉讓方以合計人民幣約36.95億元的股權轉讓對價將其持有的南嶽生物約87.98%股權轉讓給上海萊士，湖南興湘基金以合計人民幣約5.05億元的股權轉讓對價將其持有的南嶽生物12.0234%股權轉讓給上海萊士。

2024年1至6月份，上海萊士的營業收入構成為：血液製品生產及銷售佔比98.8%，檢測設備及試劑佔比1.18%，其他業務佔比0.02%。

The chairman of Shanghai RAAS is Tan Lixia, female, 61 years old, with a doctorate degree; The general manager is Jun Xu, male, 0 years old, with a doctorate degree.

截至發稿，上海萊士市值為457億元。

Daoda1997 "Stock Trend" Alert:

30. In the past 0 days, no organization has conducted a survey on Shanghai RAAS.

每經頭條（nbdtoutiao）——It has been opposed by many car companies such as Geely and Weilai, and the ideal "list" is back! This time, there is only its own weekly sales, and there is no longer an industry ranking! Netizen: Look at what the child has become

(Reporter Tsang Kin-hui)

Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Accordingly, do so at your own risk.

National Business Daily